SEC Form 4
Frazier Life Sciences Acquisition Corp. II (FLSC) insider trading
In the 12 months to Nov 19, 2026, one FLSC insider reported open-market purchases of $3.0M across 1 filing; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $3.0M
- 1 filing · Albert Cha, Chief Executive Officer
Who traded FLSC, and when
- Purchase
FLSC daily close from Oct 14, 2026 to Nov 18, 2026, between $10.05 and $10.49, last $10.05. 0 sale and 1 purchase filings by 1 insider, marked at their filing dates. Albert Cha, Chief Executive Officer: bought $3.0M across 1 filing, first filed Oct 15, 2026, last Oct 15, 2026.
Largest mark · tap a row for others
Albert Cha · Chief Executive Officer
Purchase $3,000,000
300,000 shares
Filed Oct 15, 2026
Close on filing date $10.49
Albert Cha · Chief Executive Officer
Chief Executive Officer
$3.0M boughtOpen-market trades
1 filing in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Albert Cha | Chief Executive Officer | — | $3.0M | 1 | — |
| Filed | Insider | Type | Shares | Value | Held after | Source |
|---|---|---|---|---|---|---|
traded | Albert Cha Chief Executive Officer | Purchase | 300,000 ordinary shares | $3.0M | 300,000 |
Shares are as filed (ordinary shares or ADS); values are as converted to US$ in the filing.
GET /stocks/filings/vX/form-4?tickers=FLSC&filing_date.gte=2025-11-19&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"FLSC"
],
"issuer_cik": "0002153598",
"owner_cik": "0001397906",
"accession_number": "0001193125-26-422957",
"form_type": "4",
"filing_date": "2026-10-15",
"period_of_report": "2026-10-15",
"issuer_name": "Frazier Life Sciences Acquisition Corp. II",
"issuer_trading_symbol": "FLSC",
"owner_name": "Cha Albert",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": true,
"is_other": false,
"officer_title": "Chief Executive Officer",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Class A ordinary shares",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-10-15",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 300000,
"transaction_price_per_share": 10,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 300000,
"transaction_value": 3000000,
"direct_or_indirect": "I",
"nature_of_ownership": "By Frazier Life Sciences Holdings II LLC",
"footnotes": [
{
"id": "F1",
"description": "Securities held by Frazier Life Sciences Holdings II LLC (\"Sponsor\"). Albert Cha is the sole manager of Sponsor, and Frazier Life Sciences Public Fund, L.P. is its sole equity holder. FHMLSP, L.P. is the general partner of Frazier Life Sciences Public Fund, L.P. and FHMLSP, L.L.C. is the general partner of FHMLSP, L.P. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of its or his pecuniary interest therein, if any."
}
]
},
{
"tickers": [
"FLSC"
],
"issuer_cik": "0002153598",
"owner_cik": "0001879466",
"accession_number": "0001193125-26-422957",
"form_type": "4",
"filing_date": "2026-10-15",
"period_of_report": "2026-10-15",
"issuer_name": "Frazier Life Sciences Acquisition Corp. II",
"issuer_trading_symbol": "FLSC",
"owner_name": "FHMLSP, L.P.",
"is_director": false,
"is_officer": false,
"is_ten_percent_owner": true,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Class A ordinary shares",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-10-15",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 300000,
"transaction_price_per_share": 10,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 300000,
"transaction_value": 3000000,
"direct_or_indirect": "I",
"nature_of_ownership": "By Frazier Life Sciences Holdings II LLC",
"footnotes": [
{
"id": "F1",
"description": "Securities held by Frazier Life Sciences Holdings II LLC (\"Sponsor\"). Albert Cha is the sole manager of Sponsor, and Frazier Life Sciences Public Fund, L.P. is its sole equity holder. FHMLSP, L.P. is the general partner of Frazier Life Sciences Public Fund, L.P. and FHMLSP, L.L.C. is the general partner of FHMLSP, L.P. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of its or his pecuniary interest therein, if any."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
- Counted once
- When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.
Frequently asked questions
Has Frazier Life Sciences Acquisition Corp. II's CEO sold stock?
No. Albert Cha (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is FLSC’s insider data?
These are FLSC Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track FLSC insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for FLSC every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.